Data as of Q4 2025 (Dec 31, 2025)

Genenta Science S.p.A.

(GNTA)

Financial Statements · SEC EDGAR XBRL

Source: SEC EDGAR XBRL
Breakdown
Revenues
Operating Expenses & Income
Non-Operating Income/Expense
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
19.7M
18.3M
18.2M
18.2M
15.1M